The case for & against
Bull & Bear analysis
Bearish
Narayana Hrudayalaya Ltd. (NH) is a leading healthcare service provider based in India, specializing in hospitals, clinics, health centers, and nursing homes. With a strong reputation for offering specialized medical services such as cardiac surgery, nephrology, urology, neurology, and oncology, NH is positioned prominently within the growing healthcare sector. The company’s focus on affordability and quality healthcare services has attracted a diverse patient base, placing it favorably amidst India's expanding healthcare demands.
Bull says
- ↑90% of analysts rate NH a Buy, expecting earnings rebound
- ↑Expanding bed capacity boosting daily hospital revenues
- ↑High earnings yield and strong profitability scores suggest solid returns
- ↑Positive RSI momentum indicates potential near-term rebound
- ↑Resilient demand from rising Indian healthcare needs
- ↑Robust balance sheet strength supports operational stability
Bear says
- ↓PAT margin fell from 15.7% in Q2 FY26 to 7.7% in Q1 FY27
- ↓Staff expenses growing faster than revenue, eroding margins
- ↓Stock in short-term downtrend amid foreign institutional sell-offs
- ↓Declining sales growth factor raises revenue expansion concerns
- ↓Negative free cash flow to enterprise value signals liquidity risk
- ↓High short interest highlights investor skepticism